These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34793968)

  • 1. Putative novel B-cell vaccine candidates identified by reverse vaccinology and genomics approaches to control Acinetobacter baumannii serotypes.
    Beiranvand S; Doosti A; Mirzaei SA
    Infect Genet Evol; 2021 Dec; 96():105138. PubMed ID: 34793968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New putative vaccine candidates against Acinetobacter baumannii using the reverse vaccinology method.
    Fereshteh S; Abdoli S; Shahcheraghi F; Ajdary S; Nazari M; Badmasti F
    Microb Pathog; 2020 Jun; 143():104114. PubMed ID: 32145321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Antigenic Properties of Acinetobacter baumannii Proteins as Novel Putative Vaccine Candidates Using Reverse Vaccinology Approach.
    Piri-Gharaghie T; Doosti A; Mirzaei SA
    Appl Biochem Biotechnol; 2022 Oct; 194(10):4892-4914. PubMed ID: 35670904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative novel outer membrane antigens multi-epitope DNA vaccine candidates identified by Immunoinformatic approaches to control Acinetobacter baumannii.
    Tabibpour NS; Doosti A; Sharifzadeh A
    BMC Immunol; 2023 Nov; 24(1):46. PubMed ID: 37980458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.
    Ni Z; Chen Y; Ong E; He Y
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach of virulome based reverse vaccinology for exploring and validating peptide-based vaccine candidates against the most troublesome nosocomial pathogen: Acinetobacter baumannii.
    Ahmad S; Azam SS
    J Mol Graph Model; 2018 Aug; 83():1-11. PubMed ID: 29753164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii.
    Solanki V; Tiwari V
    Sci Rep; 2018 Jun; 8(1):9044. PubMed ID: 29899345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology.
    Chiang MH; Sung WC; Lien SP; Chen YZ; Lo AF; Huang JH; Kuo SC; Chong P
    Hum Vaccin Immunother; 2015; 11(4):1065-73. PubMed ID: 25751377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse Vaccinology Approach to Potential Vaccine Candidates Against Acinetobacter baumannii.
    Shahid F; Ashraf ST; Ali A
    Methods Mol Biol; 2019; 1946():329-336. PubMed ID: 30798567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii.
    Moriel DG; Beatson SA; Wurpel DJ; Lipman J; Nimmo GR; Paterson DL; Schembri MA
    PLoS One; 2013; 8(10):e77631. PubMed ID: 24116234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
    Garg N; Singh R; Shukla G; Capalash N; Sharma P
    Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric vaccine designs against Acinetobacter baumannii using pan genome and reverse vaccinology approaches.
    Shahid F; Zaheer T; Ashraf ST; Shehroz M; Anwer F; Naz A; Ali A
    Sci Rep; 2021 Jun; 11(1):13213. PubMed ID: 34168196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets.
    Hassan A; Naz A; Obaid A; Paracha RZ; Naz K; Awan FM; Muhmmad SA; Janjua HA; Ahmad J; Ali A
    BMC Genomics; 2016 Sep; 17(1):732. PubMed ID: 27634541
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lau YT; Tan HS
    Crit Rev Microbiol; 2024 Aug; 50(4):434-449. PubMed ID: 37211625
    [No Abstract]   [Full Text] [Related]  

  • 15. Designing Multi-Antigen Vaccines Against
    McConnell MJ; Martín-Galiano AJ
    Front Immunol; 2021; 12():666742. PubMed ID: 33936107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant
    Mujawar S; Mishra R; Pawar S; Gatherer D; Lahiri C
    Front Cell Infect Microbiol; 2019; 9():203. PubMed ID: 31281799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of Outer membrane protein A.
    Jahangiri A; Rasooli I; Owlia P; Fooladi AA; Salimian J
    Microb Pathog; 2017 Apr; 105():201-210. PubMed ID: 28242426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where are we and how far is there to go in the development of an
    Ma C; Chen W
    Expert Rev Vaccines; 2021 Mar; 20(3):281-295. PubMed ID: 33554671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico identification of vaccine candidates against Klebsiella oxytoca.
    Talukdar S; Bayan U; Saikia KK
    Comput Biol Chem; 2017 Aug; 69():48-54. PubMed ID: 28570984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.